The aim of the present study was to determine the effects of a 4-week exercise training intervention on blood glucose, insulin sensitivity, BMI (body mass index) and cardiorespiratory fitness in patients with Type 2 diabetes, and to identify and establish criteria for patients who are more likely to improve their blood glucose from short-term exercise training. A randomized, controlled trial of exercise training, comprising two supervised and one non-supervised sessions of individualized cardiorespiratory and resistance exercise per week, was performed in 132 healthy patients with Type 2 diabetes (exercise training group, n = 68), with the aim of accumulating a minimum of 150 min of moderate-intensity exercise for 4 weeks. BMI, waist circumference, blood pressure, blood lipid profile, blood glucose, insulin, insulin sensitivity [calculated by HOMA IR (homoeostasis model assessment of insulin resistance) and QUICKI (quantitative insulin check index)], β-cell function (calculated by HOMA β-Cell ), HbA 1c (glycated haemoglobin) andVo 2max (maximal oxygen consumption) were measured at baseline and at 4 weeks. The exercise training group had significant improvements inVo 2max , BMI and triacylglycerols (triglycerides). There were no significant changes in blood glucose, HOMA IR , QUICKI or HOMA β-Cell . Decreases in blood glucose were significantly predicted by baseline blood glucose and HbA 1c , with these variables accounting for 15.9 % of the change in blood glucose (P < 0.001). ROC (receiver operator characteristic) curve analysis revealed that patients with a blood glucose > 8.85 mmol/l (sensitivity = 73 %, specificity = 78 %) and HbA 1c > 7.15 % (sensitivity = 79 %, specificity = 60 %) were more likely to achieve a clinically significant decrease in blood glucose. In conclusion, in apparently healthy patients with Type 2 diabetes, a 4-week exercise intervention improved cardiorespiratory fitness, BMI and triacylglycerols. Elevated blood glucose and HbA 1c predicted improvements in blood glucose.
INTRODUCTION
Meta-analyses have found that exercise training in patients with Type 2 diabetes has a small-to-moderate beneficial effect on glycaemic control [1, 2] . The original investigations on this topic have generally used interventions longer than 8 weeks, with the meta-analysis stating that the average exercise training time is approx. 60 h [1] . Shorter-term interventions offer potential for close supervision, and short-term success may increase the likelihood of ongoing lifestyle changes [3] . Furthermore, they offer a greater opportunity to individualize the exercise prescription, which is beneficial to exercise motivation and compliance [4] .
The current position statements by exercise and diabetes associations do not discuss whether certain patients may benefit more from exercise training based on their baseline health status [5, 6] . If particular patients with Type 2 diabetes do respond better to exercise training, developing methods to identify these individuals has clinical appeal and economic merit.
Therefore the aims of the present study were to determine the effects of a 4-week exercise training intervention on blood glucose, insulin sensitivity, BMI (body mass index) and cardiorespiratory fitness in patients with Type 2 diabetes, and to identify and establish criteria for patients who are more likely to improve their blood glucose from short-term exercise. Given the short duration of the present study, changes in HbA 1c (glycated haemoglobin) would not be representative and were therefore not chosen as an outcome measure. We hypothesized that the 4-week programme would decrease blood glucose and BMI, increase insulin sensitivity and cardiorespiratory fitness and that improvements in glycaemic control would be negatively associated with baseline glycaemic control.
MATERIALS AND METHODS

Patient selection
Patients with Type 2 diabetes from hospital clinics and the community were eligible for inclusion if they were between 18 and 75 years of age, excluding those with a serious co-morbidity (life expectancy < 6 months), pregnancy or known cardiovascular disease. Recruited patients (n = 248) underwent screening for occult coronary artery disease using exercise echocardiography, which excluded 25 patients. With the goal of achieving blood glucose levels < 7 mmol/l in patients with a baseline blood glucose of 8.4 + − 2.6 mmol/l, 60 patients per group provided 83 % power.
After baseline testing, patients were randomly allocated to either usual care (n = 112) or exercise training groups (n = 111) by an independent statistician using random number generation. A total of 13 groups of 15-20 patients were randomized every 3 months between 2003 and 2006, and randomization was stratified by group intake.
After randomization to exercise training or usual care, five declined the intervention and, over the 4-week period, five patients withdrew from the study and 13 did not attend for follow-up. Complete data were available for the present study from 132 patients of whom 68 were in the exercise training group.
The trial was approved by the Research Ethics Committees of the Princess Alexandra Hospital and The University of Queensland, and informed consent was obtained from all participants.
Usual care
All participants received standard risk factor intervention for Type 2 diabetes, including support to maintain a target BP (blood pressure) of < 130/80 mmHg, smoking cessation and attainment of lipid targets [LDL (low-density lipoprotein)-cholesterol < 2.6 mmol/l; triacyglycerols (triglycerides) < 1.7 mmol/l; and HDL (high-density lipoprotein)-cholesterol > 1.0 mmol/l] [7] . Usual care was co-ordinated through the Diabetes Clinic of Princess Alexandra Hospital, a teaching hospital in Brisbane, Australia. Control patients received usual care only.
Exercise training
In addition to usual care, patients randomized to the exercise training group received individualized exercise training. An accredited exercise physiologist supervised the exercise intervention, which consisted of a 4-week gym-based training programme. The aims of the programme were to (i) initiate training, (ii) achieve a minimum of 150 min/week of at least moderate-intensity exercise, and (iii) educate patients in preparation for the second stage of the intervention, ensuring they had the knowledge and skills to exercise independently with telephone counselling supervised by an accredited exercise physiologist. During each of the 4 weeks, patients attended two exercise sessions of 1 h in duration in a hospital-based gymnasium, consisting of individualized moderate-intensity cardiorespiratory and resistance training, and were asked to perform an additional 30 min of exercise at home. The programmes were designed according to fitness strengths and weaknesses, co-morbidities and complications, likes and dislikes and barriers to exercise. Cardiorespiratory training was usually chosen based on patient preference (cycling, walking, jogging, stepping or rowing). Moderate intensity was defined as a rating of perceived exertion of 12-13 (Borg 20 point scale). Resistance exercises were initially performed using gym equipment (both machine and free weight) and progressed to exercises modified to equipment that patients could take home for the second stage of the intervention (Thera-Bands ® and Fitballs). Participants were encouraged to reach failure (not able to complete another repetition) from 12-15 repetitions for each exercise for two to three sets. The home-based session generally consisted of walking, jogging, swimming and home-based resistance exercises at moderate intensity. [8, 9] .
Clinical and laboratory measurements
Cardiorespiratory fitness
Cardiorespiratory fitness was assessed by indirect calorimetry (Vmax29c; SensorMedics), measuringVo 2max (maximal oxygen consumption) during a graded exercise test to exhaustion. BP and cardiac status (using a 12-lead ECG) were monitored during the exercise test (CASE; GE Medical Systems).
Statistical analysis
All data was tested for normality with the KolmogorovSmirnov test and the Normal Q-Q plot, where appropriate. The following data required log transformation: BMI, glucose, HbA 1c , HOMA IR , HOMA β-Cell , QUICKI, triacyglycerols, HDL, SBP (systolic BP), DBP (diastolic BP) andVo 2max . General linear modelling with repeated measures ANOVA was used to assess group and time effects. A group-time interaction was used to establish differences between groups. Paired Student's t tests were used to assess within-group changes. The mean absolute change was determined from the individual change. Pearson correlations were used to assess associations, and multiple regression analysis was used to determine significant independent predictors, with P < 0.10 in bivariate testing used as a requirement to enter the model. Significance was assumed if P < 0.05. ROC (receiver operator characteristic) curves were used to determine cut-off values associated with improvements in blood glucose. A clinically significant improvement in blood glucose was selected as 1 mmol/l [10] . All baseline variables that correlated significantly with a change in blood glucose were plotted to determine the specificity and sensitivity of the measure in predicting a clinically significant change in blood glucose. Statistical analyses were conducted using standard statistical software (SPSS version 15.0 for Windows). Table 1 provides a comparison of baseline demographic, clinical and laboratory results in the exercise training and control groups, and their change with exercise training. The exercise training group had a significantly (P < 0.05) higher SBP and lowerVo 2max compared with the control group at baseline.
RESULTS
Patient characteristics
Efficacy of the exercise training
Exercise training led to significant improvements iṅ Vo 2max , BMI and triacylglycerols compared with controls (Table 1) . Waist circumference significantly (P < 0.05) decreased within the exercise training group; however, exercise training had no effect on blood glucose, insulin sensitivity (QUICKI and HOMA IR ) or β-cell function (HOMA β-Cell ).
Correlates of changes in blood glucose and insulin sensitivity
As there were no significant (P > 0.05) group differences for blood glucose and markers of insulin sensitivity, results from both groups were pooled to determine patients who were more likely to improve their blood glucose and insulin sensitivity. Analysis of the results from within the intervention group only (results not shown) showed similar results to the pooled analysis. Table 2 shows the significant bivariate associations with changes in blood glucose, HOMA IR and QUICKI. The change in blood glucose was significantly (P < 0.05) negatively correlated with baseline blood glucose and baseline HbA 1c , and significantly (P < 0.05) positively correlated with a change in total cholesterol and triacylglycerols. All four variables were entered into a multiple regression model which revealed that baseline blood glucose (β = − 0.677, P < 0.001), baseline HbA 1c (β = − 0.288, P = 0.019) and changes in triacyglycerols (β = 0.191, P = 0.021) were significant independent predictors of the change in blood glucose, with the combination of these variables accounting for 30 % of the change in blood glucose (P < 0.001). Furthermore, when including only baseline blood glucose and HbA 1c in the model, it still accounted for 15.9 % (P < 0.001) of the change in glucose (β = − 0.580, P < 0.001, and β = − 0.262, P = 0.038 respectively) ( Figure 1 ).
The change in HOMA IR was significantly (P < 0.05) negatively correlated with baseline HOMA IR , waist circumference and baseline insulin and significantly (P < 0.05) positively correlated with the change in BMI, total cholesterol and triacylglycerols. These variables were entered into a multiple regression model which showed that baseline HOMA IR (β = − 0.307, P < 0.001), a change in BMI (β = 0.343, P < 0.001) and a change in total cholesterol (β = 0.198, P = 0.021) were significant independent predictors of a change in HOMA IR , with the combination of these variables accounting for 30 % of the change in HOMA IR (P < 0.001). Furthermore, when including only baseline HOMA IR , it still accounted for 15 % (P < 0.001) of the change in HOMA IR (β = − 0.388, P < 0.001).
The change in QUICKI was significantly (P < 0.05) negatively correlated with baseline QUICKI, the change in BMI and triacylglycerols, and significantly (P < 0.05) positively correlated with baseline waist circumference and baseline insulin. Multiple regression with these variables revealed that baseline QUICKI (β = − 0.442, P < 0.001), the change in BMI (β = 0.227, P = 0.007) and the change in triacylglycerols (β = 0.168, P = 0.007) were significant independent predictors of the change in QUICKI, with the combination of these three accounting for 39 % of the change in QUICKI (P < 0.001). Furthermore, when including only baseline QUICKI in the model, it still accounted for 23 % (P < 0.001) of the change in QUICKI (β = − 0.476, P < 0.001).
Determining thresholds of the benefit for exercise training
ROC curve analyses were conducted to identify patients who would have the most benefit on blood glucose from exercise training. In this analysis, a decrease equivalent to 1 mmol/l was used to define a clinically significant improvement in blood glucose [10] . Baseline blood glucose and HbA 1c (the only significant baseline predictors of a change in blood glucose) were plotted to determine the specificity and sensitivity of optimal cut-offs in predicting a clinically significant improvement in blood glucose. The cut-off values determined for baseline blood glucose and HbA 1c were 8.85 mmol/l (sensitivity = 74 %, specificity = 78 %) and 7.15 % (sensitivity = 79 %, specificity = 60 %) respectively. Baseline blood glucose had a comparable AUC (area under the curve) of 0.80 (P < 0.001) and sensitivity and a higher specificity compared with baseline HbA 1c (AUC = 0.75, P < 0.001). Patients who had baseline blood glucose above the cut-off value had significantly decreased blood glucose compared with those patients below the cut-off (change in glucose, − 0.82 + − 0.38 mmol/l compared with 0.24 + − 0.13 mmol/l respectively; P < 0.002).
DISCUSSION
In the present study, an individualized 4-week exercise training intervention, using a combination of cardiorespiratory and resistance training exercises, in patients with Type 2 diabetes was effective in producing a small, but significant, increase in cardiorespiratory fitness and small, but significant, decreases in BMI and triacylglycerols, although the intervention did not significantly effect blood glucose or markers of insulin sensitivity. However, patients with a higher blood glucose, HbA 1c and HOMA IR and a lower QUICKI score were more likely to have an improvement in their glycaemic control and markers of insulin sensitivity over 4 weeks. The degree of improvement in BMI and blood lipid profile was associated with improvements in blood glucose and insulin sensitivity. Patients with Type 2 diabetes and a baseline blood glucose > 8.85 mmol/l and HbA 1c > 7.15 % derived the greatest benefit.
Treatment effects
The exercise training in the present trial resulted in a significant increase inVo 2max in the exercise training group compared with controls. This is consistent with findings from a meta-analysis of an increase of 2.1 ml · kg −1 of body weight · min −1 in patients with Type 2 diabetes undergoing aerobic exercise training [3] .
Changes in BMI and body composition reported previously are mixed, with some studies reporting improvements [11] [12] [13] or no improvements [14] [15] [16] [17] [18] in body composition, usually measured by changes in BMI or body mass. Our present results were consistent with this pattern, with small significant decreases in BMI. The varying modes of exercise (resistance compared with cardiorespiratory) and assessment techniques in more homogeneous patients may be responsible for such findings. Although there was no group difference, there was a significant decrease of 1 cm in waist circumference within the intervention group from baseline to posttraining. It is therefore likely that the decrease observed in BMI is related to decreases in fat mass.
Triacylglycerols were also significantly decreased in the intervention group compared with controls. Some similar decreases have been reported from exercise training studies in Type 2 diabetes patients utilizing three sessions each week for training periods varying from 6 weeks to 1 year [19] [20] [21] [22] [23] , although a greater range and even increases have been shown [24] . This variation is likely to be a result of dietary changes that were not controlled during this 4-week training period or in other exercise training studies.
Contributions to blood glucose and insulin sensitivity effects
Small, non-significant, changes were observed over the 4-week period in blood glucose, HOMA IR , QUICKI and HOMA β-Cell respectively.
There are several potential reasons why exercise training had no significant effect on blood glucose or markers of insulin sensitivity. First, it is possible that the exercise prescription may not have been long enough, had sufficient volume of training or was intense enough to yield these improvements. Previous exercise intervention studies have shown improvements in HbA 1c and markers of insulin sensitivity (insulin resistance and glucose disposal rate) from cardiorespiratory training [15, 17, 25] , cardiorespiratory and resistance training [12, 18, 26] or resistance training [14, 21, 22, 27] , with all of these interventions utilizing three or more sessions a week for an average of 58 h of training and prescribing > 150 min/week of moderate-intensity exercise [1] . In comparison, the present study utilized 8 h of supervised training and 4 h of unsupervised training. Higher volumes (min/week) and intensities of exercise have been shown to produce greater improvements in glycaemic control and insulin resistance [27] [28] [29] ; furthermore, the shorter duration (4 weeks) may not have been sufficient. Nonetheless, the intervention used in the present study was based on current recommendations, which raises concerns regarding the appropriateness of these, especially for short-term results.
A second explanation for the lack of effect on blood glucose and markers of insulin resistance may relate to patient selection. We recruited patients from a diabetes clinic and the general community, resulting in a heterogeneous population that we believe maybe more representative of the overall Type 2 diabetes patient population. Patients with poor glycaemic control and markers of insulin sensitivity (HOMA IR and QUICKI) were significantly more likely to have an improvement in their glycaemic control. Baseline blood glucose, HbA 1c , HOMA IR and QUICKI were not only negatively correlated, but were all significant independent predictors of changes in glycaemic control and markers of insulin sensitivity. ROC curve analysis revealed that the cut-off values for improvements in blood glucose were 8.85 mmol/l for baseline blood glucose and 7.15 % for baseline HbA 1c (Figure 1 ). Current exercise training guidelines [5, 6, 30] do not specify whether all or selected patients with Type 2 diabetes would respond better to exercise training. Using the ROC curve analysis, 35 % of the patients in the present study were above the proposed cut-off value for blood glucose and 50 % for HbA 1c . Indeed, a sub-group analysis showed that patients who had baseline blood glucose above the proposed cut-off value significantly improved their blood glucose more than those patients below the cut-off. These thresholds may be considered as selection criteria for patients with Type 2 diabetes for priority to receive short-term exercise training. This conclusion is not suggesting that only selected patients with Type 2 diabetes should be targeted, rather, given the highly resourcedependent nature of exercise interventions, priority could be directed towards these selected patients. These findings are concordant with previous studies showing that patients with poorer baseline glycaemic control and body composition were more likely to improve their glycaemic control to both exercise [18] and pharmaceutical [31] interventions. However, improvements in insulin sensitivity were previously only shown in non-obese patients with Type 2 diabetes [17] . However, even the non-obese patients recruited for that particular study had a 15 % higher blood glucose and a 26 % higher HbA 1c compared with the intervention group in the present study. Table 3 shows a comparison of the variation of patients with Type 2 diabetes used in exercise intervention studies. Seven of the 12 studies reported no effects of exercise training on blood glucose. In comparison with patients with Type 2 diabetes in other investigations, the patients enrolled in the present study had the lowest blood glucose, a comparatively low HbA 1c and the largest variation in age and cardiorespiratory fitness. This is probably a result of subject recruitment with many of the previous studies recruiting patients who were overweight, nonobese or were within a specific age group. As explained in the Materials and methods section, recruitment for the present study comprised apparently healthy patients from the diabetes clinic and the community.
Very few studies have reported changes in HOMA IR or QUICKI as a result of exercise training. One study reported 10000 steps/day for 6 weeks had positive effects on QUICKI and blood glucose levels, although the lack of a control group limits this finding [32] . Another study showed weekly lifestyle education (including diet and exercise) for 16 weeks achieved an average of 8.6 h/per week of activity, which resulted in no change in HOMA IR but a significant decrease in blood glucose [13] . On the basis of previous studies, it appears that findings on the effect of exercise training on glycaemic control and insulin sensitivity greatly depend on the measures used to assess these changes. It is well recognized that HbA 1c is a robust indictor of glycaemic control; however, as mentioned previously, due to the short duration of our Changes in blood lipid profile (total cholesterol and triacylglycerols) and BMI were also associated with and predictive of changes in blood glucose. Multiple regression models containing baseline blood glucose, baseline HbA 1c and changes in blood lipid profile and BMI were able to significantly predict 30 % of the change in blood glucose, 30.3 % of the change in HOMA IR and 28.7 % of the change in QUICKI respectively. Previous studies have linked decreases in BMI or fat loss to improvements in glycaemic control [2, 15] , although some reports have suggested that these changes are independent of each other [14, 33] . However, the results of the present study do support a link between decreases in BMI and improvements in glycaemic control, which is likely to be, at least in part, due to the use of cardiorespiratory training in the exercise programme.
Potential limitations of the present study were the use of the outcome measures, blood glucose, HOMA IR and QUICKI, to represent glycaemic control and insulin sensitivity, although these techniques have been used previously in studies investigating the effects of exercise in patients with Type 2 diabetes [13, 27, 32] . More sensitive measures, such as euglycaemic clamp tests, would give further insight into the patients' glycaemic control and insulin sensitivity; however, the time required for using this technique was prohibitive in such a large number of patients. An additional limitation may have been due to the non-control of medication. However, importantly, medication profiles did not change over the intervention period and, therefore, it is likely that medication did not influence the results.
Conclusions
Exercise training for 4 weeks had no effect on blood glucose or markers of insulin sensitivity in patients with Type 2 diabetes. The short-term training did result in a small, but significant, increase in cardiorespiratory fitness and decreases in BMI and triacylglycerols. The intervention followed current guidelines ( 150 min of moderate intensity exercise per week) which are less than those used in previous studies that have reported a positive result, particularly over short durations. In addition, we provide evidence that the metabolic health of the patients recruited may be responsible for the lack of an effect. Pooled data indicated that elevated blood glucose and HbA 1c were associated with, and predictive of, improvements in blood glucose. If resources to deliver exercise training to patients with Type 2 diabetes are limited, then priority should be directed to patients with poor metabolic health. It is proposed that patients with blood glucose > 8.85 mmol/l and a HbA 1c > 7.15 % benefit more.
